9-98060802-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_018946.4(NANS):​c.153T>C​(p.Ala51Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.524 in 1,613,458 control chromosomes in the GnomAD database, including 231,026 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.61 ( 30508 hom., cov: 33)
Exomes 𝑓: 0.52 ( 200518 hom. )

Consequence

NANS
NM_018946.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.117

Publications

22 publications found
Variant links:
Genes affected
NANS (HGNC:19237): (N-acetylneuraminate synthase) This gene encodes an enzyme that functions in the biosynthetic pathways of sialic acids. In vitro, the encoded protein uses N-acetylmannosamine 6-phosphate and mannose 6-phosphate as substrates to generate phosphorylated forms of N-acetylneuraminic acid (Neu5Ac) and 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid (KDN), respectively; however, it exhibits much higher activity toward the Neu5Ac phosphate product. In insect cells, expression of this gene results in Neu5Ac and KDN production. This gene is related to the E. coli sialic acid synthase gene neuB, and it can partially restore sialic acid synthase activity in an E. coli neuB-negative mutant. [provided by RefSeq, Jul 2008]
TRIM14 (HGNC:16283): (tripartite motif containing 14) The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The protein localizes to cytoplasmic bodies and its function has not been determined. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 9-98060802-T-C is Benign according to our data. Variant chr9-98060802-T-C is described in ClinVar as [Benign]. Clinvar id is 1250394.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.117 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.863 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NANSNM_018946.4 linkc.153T>C p.Ala51Ala synonymous_variant Exon 2 of 6 ENST00000210444.6 NP_061819.2
TRIM14XM_047424162.1 linkc.*29-24989A>G intron_variant Intron 6 of 6 XP_047280118.1
NANSXM_011518787.3 linkc.-359T>C upstream_gene_variant XP_011517089.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NANSENST00000210444.6 linkc.153T>C p.Ala51Ala synonymous_variant Exon 2 of 6 1 NM_018946.4 ENSP00000210444.5 Q9NR45
NANSENST00000480925.1 linkn.192T>C non_coding_transcript_exon_variant Exon 2 of 2 2
NANSENST00000495319.1 linkn.194T>C non_coding_transcript_exon_variant Exon 2 of 5 3

Frequencies

GnomAD3 genomes
AF:
0.606
AC:
92099
AN:
152012
Hom.:
30453
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.870
Gnomad AMI
AF:
0.586
Gnomad AMR
AF:
0.635
Gnomad ASJ
AF:
0.445
Gnomad EAS
AF:
0.324
Gnomad SAS
AF:
0.665
Gnomad FIN
AF:
0.398
Gnomad MID
AF:
0.541
Gnomad NFE
AF:
0.497
Gnomad OTH
AF:
0.597
GnomAD2 exomes
AF:
0.542
AC:
136386
AN:
251458
AF XY:
0.539
show subpopulations
Gnomad AFR exome
AF:
0.881
Gnomad AMR exome
AF:
0.667
Gnomad ASJ exome
AF:
0.444
Gnomad EAS exome
AF:
0.322
Gnomad FIN exome
AF:
0.395
Gnomad NFE exome
AF:
0.496
Gnomad OTH exome
AF:
0.518
GnomAD4 exome
AF:
0.516
AC:
753969
AN:
1461328
Hom.:
200518
Cov.:
52
AF XY:
0.518
AC XY:
376842
AN XY:
727030
show subpopulations
African (AFR)
AF:
0.889
AC:
29777
AN:
33478
American (AMR)
AF:
0.662
AC:
29612
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.439
AC:
11483
AN:
26128
East Asian (EAS)
AF:
0.301
AC:
11958
AN:
39690
South Asian (SAS)
AF:
0.656
AC:
56554
AN:
86244
European-Finnish (FIN)
AF:
0.396
AC:
21140
AN:
53410
Middle Eastern (MID)
AF:
0.548
AC:
3158
AN:
5768
European-Non Finnish (NFE)
AF:
0.503
AC:
558978
AN:
1111510
Other (OTH)
AF:
0.519
AC:
31309
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
19652
39304
58957
78609
98261
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16464
32928
49392
65856
82320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.606
AC:
92214
AN:
152130
Hom.:
30508
Cov.:
33
AF XY:
0.601
AC XY:
44653
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.870
AC:
36137
AN:
41530
American (AMR)
AF:
0.635
AC:
9707
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.445
AC:
1544
AN:
3470
East Asian (EAS)
AF:
0.324
AC:
1676
AN:
5178
South Asian (SAS)
AF:
0.664
AC:
3199
AN:
4816
European-Finnish (FIN)
AF:
0.398
AC:
4201
AN:
10566
Middle Eastern (MID)
AF:
0.544
AC:
160
AN:
294
European-Non Finnish (NFE)
AF:
0.497
AC:
33802
AN:
67970
Other (OTH)
AF:
0.595
AC:
1255
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1659
3318
4976
6635
8294
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
732
1464
2196
2928
3660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.543
Hom.:
37545
Bravo
AF:
0.632
Asia WGS
AF:
0.553
AC:
1926
AN:
3478
EpiCase
AF:
0.491
EpiControl
AF:
0.505

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Spondyloepimetaphyseal dysplasia, Genevieve type Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
13
DANN
Benign
0.76
PhyloP100
0.12
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=81/19
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13049; hg19: chr9-100823084; COSMIC: COSV52965592; API